Clinical trial
Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents
NCT00067574 · University of North Carolina, Chapel Hill, Other · Withdrawn
Key facts
| NCT number | NCT00067574 |
|---|---|
| Title | Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents |
| Official title | Structured Treatment Interruption as an Autovaccination Approach to Enhance Immune Based HIV-1 Control in an Adolescent/Young Adult Population |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral |
| Interventions | Structured treatment interruption |
| Enrollment | 0 |
| Start date | Jul 1, 2003 |
| First posted | Aug 26, 2003 |
| Last update posted | Mar 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: